Article Information
History
- August 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Derin Sevenler1,2,
- Xin Niu3,
- Sandy Dossantos1,
- Mehmet Toner1,2,
- Tim R. Cressey4,5,
- Rebecca Sandlin1,2 and
- Paul Drain3,6,*
- 1Center for Engineering in Medicine & Surgery, Massachusetts General Hospital, Charlestown, MA, USA
- 2Harvard Medical School, Boston, MA, USA
- 3Department of Global Health, University of Washington, Seattle, USA
- 4PHPT/IRD-MIVEGEC, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
- 5Department of Molecular & Clinical Pharmacology, University of Liverpool, UK
- 6Departments of Epidemiology and Medicine, University of Washington, Seattle, USA
- ↵*Corresponding Author. email: pkdrain{at}uw.edu, tel: 206-520-3820
Posted August 24, 2021.
Point-of-care semiquantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
